Cargando…
Fibrosis driving myofibroblast precursors in MPN and new therapeutic pathways
Autores principales: | Gleitz, Hélène F.E., Pritchard, Jessica E., Kramann, Rafael, Schneider, Rebekka K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925660/ https://www.ncbi.nlm.nih.gov/pubmed/35309783 http://dx.doi.org/10.1097/HS9.0000000000000216 |
Ejemplares similares
-
MPN-433: Outcomes of COVID-19 in Hematopoietic Stem Cell Transplant Recipients: A Single-Institution, Observational Study
por: Dwabe, Sami, et al.
Publicado: (2021) -
Relationship between disease biology and clinical phenotype in myeloproliferative neoplasms
por: Nangalia, Jyoti
Publicado: (2019) -
MF management
por: Bose, Prithviraj, et al.
Publicado: (2019) -
Myeloproliferative neoplasms
por: Cross, Nick
Publicado: (2019) -
Biology and therapeutic targeting of molecular mechanisms in MPNs
por: How, Joan, et al.
Publicado: (2023)